- Review
Epigallocatechin Gallate as a Targeted Therapeutic Strategy Against the JAK2V617F Mutation: New Perspectives for the Treatment of Myeloproliferative Neoplasms and Acute Myeloid Leukemia
- Leidivan Sousa Da Cunha,
- Isabelle Magalhães Farias,
- Beatriz Maria Dias Nogueira,
- Caio Bezerra Machado,
- Flávia Melo Cunha De Pinho Pessoa,
- Deivide De Sousa Oliveira,
- Guilherme Passos de Morais,
- André Pontes Thé,
- Patrícia Maria Pontes Thé and
- Manoel Odorico De Moraes Filho
- + 2 authors
The JAK2V617F mutation is a major molecular factor in Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) and has been increasingly associated with clonal progression to acute myeloid leukemia (AML), resulting in a poorer prognosis a...

